Counterfeit drugs becoming big business worldwide

The criminal practice has largely been relegated to poor countries with lax regulations. But with more medicines and drug ingredients for sale in the U.S. being manufactured overseas, American authorities are afraid more counterfeits will find their way into this country, putting patients’ lives at risk.

The Avastin discovery follows other recent instances in the U.S. of counterfeiting, involving such drugs as Viagra, the cholesterol medicine Lipitor and the weight-loss pill Alli.

“We do know there are counterfeits continuing to try and make their way onto the U.S.

Full Post…

Prostate Cancer Screening and Men Over 75

You may have read in the news the latest prostate cancer screening recommendation issued by the United States Preventive Services Task Force (USPSTF). This federal advisory panel also called for comments regarding its recommendation that, “For men age 75 years or older and for those whose life expectancy is 10 years or fewer, the incremental benefit from treatment of prostate cancer detected by screening is small to none.”

This advice is not new. The same recommendation was made three years ago. The r

Full Post…

New Innovation Challenge Will Help People with Disabilities Access Their Health Records

 | 

Wil Yu / Special Assistant Innovations ONC Office of the Chief Scientist

We are extremely excited to announce the launch of a new Investing in Innovations mobile app challenge, the EHR Accessibility Module Challenge.

Improving Access to Health Records

ONCs mission includes reducing health disparities, ensuring secure and protected patient health information, and reducing health care costs. A

Full Post…

NIAID News Release: Media Availability: NIAID Scientists Consider 200 Years of Infectious Diseases

WHAT: Unpredictable, ever-changing and with potentially far-reaching effects on the fates of nations, infectious diseases are compelling actors in the drama of human history, note scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. In an essay marking 200 years of publication of the New England Journal of Medicine, NIAID Director Anthony S. Fauci, M.D., and coauthor David M. Morens, M.D., trace key advances in understanding and combatting infectious diseases and outline ways in which the contest between microbes and man might play out in decades to come.

Full Post…